These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9236530)

  • 1. Lymphomas during long-term methotrexate therapy.
    Kamel OW
    Arch Dermatol; 1997 Jul; 133(7):903-4. PubMed ID: 9236530
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 4. Position statement: immunomodulator therapy for inflammatory Bowel disease.
    Lavy A; Chowers Y; Odes HS; Eliakim R;
    Isr Med Assoc J; 2003 Mar; 5(3):164-9. PubMed ID: 12725133
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate.
    Menke DM; Griesser H; Moder KG; Tefferi A; Luthra HS; Cohen MD; Colon-Otero G; Lloyd RV
    Am J Clin Pathol; 2000 Feb; 113(2):212-8. PubMed ID: 10664623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern drug therapy in rheumatic diseases.
    Molony J
    Ir Med J; 1975 Jun; Suppl():36-7. PubMed ID: 1081096
    [No Abstract]   [Full Text] [Related]  

  • 7. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?
    Starkebaum G
    J Rheumatol; 2001 Dec; 28(12):2573-5. PubMed ID: 11764198
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections.
    Vassilopoulos D; Calabrese LH
    Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis].
    Baixauli Rubio A; Rodríguez Górriz E; Campos Fernández C; Calvo Catalá J; García Vicente S
    An Med Interna; 2003 May; 20(5):276-7. PubMed ID: 12831311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spontaneous regression of immunodeficiency associated plasmablastic lymphoma related to methotrexate after decrease of dosage].
    García-Noblejas A; Velasco A; Cannata-Ortiz J; Arranz R
    Med Clin (Barc); 2013 Jun; 140(12):569-70. PubMed ID: 23177304
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of vulvovaginal erosive and stenosing lichen planus by surgical dilatation and methotrexate.
    Kortekangas-Savolainen O; Kiilholma P
    Acta Obstet Gynecol Scand; 2007; 86(3):339-43. PubMed ID: 17364310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of severe atopic dermatitis with methotrexate.
    Balasubramaniam P; Ilchyshyn A
    Clin Exp Dermatol; 2005 Jul; 30(4):436-7. PubMed ID: 15953091
    [No Abstract]   [Full Text] [Related]  

  • 14. Folic acid supplementation and methotrexate therapy for psoriasis.
    Hughes R; Harries M; Chalmers RJ; Kirby B
    J Am Acad Dermatol; 2006 Aug; 55(2):366-7. PubMed ID: 16844540
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of disseminated granuloma annulare with methotrexate.
    Plotner AN; Mutasim DF
    Br J Dermatol; 2010 Nov; 163(5):1123-4. PubMed ID: 20586778
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic therapy of psoriasis using methotrexate.
    Smith KC
    Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate.
    López-Ferrer A; Puig L; Moreno G; Camps-Fresneda A; Palou J; Alomar A
    Eur J Dermatol; 2010; 20(4):511-2. PubMed ID: 20395191
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
    Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
    J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow nail pigmentation due to methotrexate.
    Malka N; Reichert S; Trechot P; Barbaud A; Schmutz JL
    Dermatology; 1998; 197(3):276. PubMed ID: 9867364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.